PKC-mediated toxicity of elevated glucose concentration on cardiomyocyte function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 4, 2014, Pages

  Sims, Mark W ^a   Winter, James ^a   Brennan, Sean ^a   Norman, Robert I ^b   Ng, G André ^a   Squire, Iain B ^a   Rainbow, Richard D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Arrhythmia; Glucose; Hyperglycemia; Ischemic preconditioning; Protein kinase C

Indexed keywords

CALCIUM; GLUCOSE; PROTEIN KINASE C; ISOENZYME;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CARDIOTOXICITY; CELL FUNCTION; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GUINEA PIG; HEART MUSCLE CELL; HEART PROTECTION; ISCHEMIC PRECONDITIONING; NONHUMAN; PATCH CLAMP TECHNIQUE; PHENOTYPE; PRIORITY JOURNAL; RAT; REPERFUSION; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; HEART CONTRACTION; HEART INFARCTION PREVENTION; HEART VENTRICLE; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHYSIOLOGY; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; GLUCOSE; HEART VENTRICLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOENZYMES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEIN KINASE C; RATS; RATS, WISTAR;

EID: 84906076838     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00894.2013     Document Type: Article

References (41)

1. Budas GR, Churchill EN, Mochly-Rosen D. Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharm Res 55: 523-536, 2007.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355: 773-778, 2000.
3. Ceriello A. Acute hyperglycaemia: a "new" risk factor during myocardial infarction. Eur Heart J 26: 328-331, 2005.
4. Chen H, Shen WL, Wang XH, Chen HZ, Gu JZ, Fu J, Ni YF, Gao PJ, Zhu DL, Higashino H. Paradoxically enhanced heart tolerance to ischaemia in type 1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 33: 910-916, 2006.
5. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW 2nd, and Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
6. Chu S, Bohlen HG. High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism. Am J Physiol Renal Physiol 287: F384-F392, 2004.
7. Churchill EN, Mochly-Rosen D. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans 35: 1040-1042, 2007.
8. Dai S, Hall DD, Hell JW. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 89: 411-452, 2009.
9. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P; American Heart Association Diabetes Committee of the Council on Nutrition Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117: 1610-1619, 2008.
10. Gholap NN, Mehta RL, Ng L, Davies MJ, Khunti K, Squire IB. Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study. BMJ Open 2: e001596, 2012.
11. Gordin D, Forsblom C, Ronnback M, Groop PH. Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med 25: 101-105, 2008.
12. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW, Granger CB. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27: 1289-1297, 2006.
13. Hreiche R, Plante I, David LP, Simard C, Turgeon J, Drolet B. Impact of glucose concentration on cardiac ventricular repolarization under I Kr/I Ks blocking agents. J Mol Cell Cardiol 47: 210-220, 2009.
14. Hudman D, Standen NB. Protection from the effects of metabolic inhibition and reperfusion in contracting isolated ventricular myocytes via protein kinase C activation. J Mol Cell Cardiol 37: 579-591, 2004.
15. Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 100: 465-471, 2008.
16. Ikeda A, Matsushita S, Sakakibara Y. Inhibition of protein kinase C beta ameliorates impaired angiogenesis in type I diabetic mice complicating myocardial infarction. Circ J 76: 943-949, 2012.
17. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol Heart Circ Physiol 275: H721-H725, 1998.
18. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomesbased measure of risk. Circulation 117: 1018-1027, 2008.
19. Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, Allard MF. Regulation of myocardial fatty acid oxidation by substrate supply. Am J Physiol Heart Circ Physiol 281: H1561-H1567, 2001.
20. Malhotra A, Begley R, Kang BP, Rana I, Liu J, Yang G, Mochly-Rosen D, Meggs LG. PKC-P-dependent survival signals in diabetic hearts. Am J Physiol Heart Circ Physiol 289: H1343-H1350, 2005.
21. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26: 57-65, 1995.
22. Marfella R, Rossi F, Giugliano D. Hyperglycemia and QT interval: time for re-evaluation. Diabetes Nutr Metab 14: 63-65, 2001.
23. Marques JL, George E, Peacey SR, Harris ND, Macdonald IA, Cochrane T, Heller SR. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med 14: 648-654, 1997.
24. Miele C, Paturzo F, Teperino R, Sakane F, Fiory F, Oriente F, Ungaro P, Valentino R, Beguinot F, Formisano P. Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization. J Biol Chem 282: 31835-31843, 2007.
25. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
26. National Institute for Health and Clinical Excellence National Institute for Health and Clinical Excellence: Guidance. In: Hyperglycaemia in Acute Coronary Syndromes: Management of Hyperglycaemia in People with Acute Coronary Syndromes. London, UK: National Institute for Health and Clinical Excellence, 2011.
27. Rainbow RD, Hardy ME, Standen NB, Davies NW. Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells. J Physiol 575: 833-844, 2006.
28. + channels through different protein kinase C isoenzymes. Cardiovasc Res 83: 493-500, 2009.
29. ATP channels during metabolic stress. J Mol Cell Cardiol 39: 637-646, 2005.
30. ATP channels during metabolic inhibition by an indirect mechanism. Cardiovasc Res 61: 570-579, 2004.
31. Rodrigo GC, Samani NJ. Ischemic preconditioning of the whole heart confers protection on subsequently isolated ventricular myocytes. Am J Physiol Heart Circ Physiol 294: H524-H531, 2008.
32. Schnell O, Schafer O, Kleybrink S, Doering W, Standl E, Otter W. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 27: 455-460, 2004.
33. Shizukuda Y, Reyland ME, Buttrick PM. Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol 282: H1625-H1634, 2002.
34. Squire IB, Nelson CP, Ng LL, Jones DR, Woods KL, Lambert PC. Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice. Clin Sci 118: 527-535, 2010.
35. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D; Task Force on the Management of STSegment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33: 2569-2619, 2012.
36. v channels: effects of glucose and PKC. Am J Physiol Cell Physiol 297: C788-C796, 2009.
37. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper-and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26: 1255-1261, 2005.
38. Tang WH, Cheng WT, Kravtsov GM, Tong XY, Hou XY, Chung SK, Chung SS. Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress. Am J Physiol Cell Physiol 299: C643-C653, 2010.
39. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40: 1748-1754, 2002.
40. Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 93: 1542-1546, 2007.
41. Winter J, Brack KE, Ng GA. The acute inotropic effects of cardiac contractility modulation (CCM) are associated with action potential duration shortening and mediated by beta1-adrenoceptor signaling. J Mol Cell Cardiol 51: 252-262, 2011.